FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2513500912> ?p ?o ?g. }

• W2513500912 endingPage "506" @default.
• W2513500912 startingPage "500" @default.
• W2513500912 abstract "Background Cardiometabolic disruptions such as insulin resistance, obesity, high blood pressure, hyperglycemia, and dyslipidemias, are known to increase the risk for cardiovascular and metabolic diseases such as type 2 diabetes mellitus and atherosclerosis. Several screening tools for assessing cardiometabolic risk have been developed including the TG/HDLc ratio, which has been, demonstrated to possess a strong association with insulin resistance and coronary disease. Dietary modifications, together with regular moderate exercise have proven to be effective in attenuating cardiometabolic disruptions. However, they often exhibit poor long-term patient compliance. Nutraceutics, including (−)-epicatechin (EPI), have gained increasing interest as coadjuvant effective and safe therapies that are able to attenuate hypertension, hyperglycemia, hyperinsulinemia, hypertriglyceridemia and hypoalphalipoproteinemia. Methods The aims of this study were: 1) to compare the in vitro effect of EPI vs. (+)-catechin on fructose induced triglyceride accumulation and mitochondrial function in Hep2 cells in culture, 2) to evaluate the efficacy of EPI treatment in reducing fasting blood triglycerides and improving the TG/HDLc ratio in hypertriglyceridemic patients with a total daily dose of 100 mg of EPI. Secondary clinical variables included total cholesterol, LDLc, fructosamine, glucose, insulin, and high sensitivity C-reactive protein blood levels. Results and conclusion Our results provide preliminary evidence as to favorable effects of EPI on glycemia homeostasis, lipid profile and systemic inflammation such bioactive actions are not class-effects (i.e. limited to their antioxidant potential) but instead, may result from the specific activation of associated downstream signaling pathways since catechin has no effects." @default.
• W2513500912 created "2016-09-16" @default.
• W2513500912 creator A5003150097 @default.
• W2513500912 creator A5004471228 @default.
• W2513500912 creator A5009540446 @default.
• W2513500912 creator A5011798535 @default.
• W2513500912 creator A5021022068 @default.
• W2513500912 creator A5026554167 @default.
• W2513500912 creator A5041985799 @default.
• W2513500912 creator A5042394356 @default.
• W2513500912 creator A5050261399 @default.
• W2513500912 creator A5077187848 @default.
• W2513500912 creator A5081352430 @default.
• W2513500912 date "2016-11-01" @default.
• W2513500912 modified "2023-10-13" @default.
• W2513500912 title "A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects" @default.
• W2513500912 cites W1572193815 @default.
• W2513500912 cites W1964192751 @default.
• W2513500912 cites W1964367469 @default.
• W2513500912 cites W1967850240 @default.
• W2513500912 cites W1972602644 @default.
• W2513500912 cites W1974851838 @default.
• W2513500912 cites W1976132744 @default.
• W2513500912 cites W1991716051 @default.
• W2513500912 cites W1998990919 @default.
• W2513500912 cites W2019217568 @default.
• W2513500912 cites W2026264178 @default.
• W2513500912 cites W2031843555 @default.
• W2513500912 cites W2033991878 @default.
• W2513500912 cites W2035951019 @default.
• W2513500912 cites W2037273234 @default.
• W2513500912 cites W2039249972 @default.
• W2513500912 cites W2041572943 @default.
• W2513500912 cites W2050126109 @default.
• W2513500912 cites W2064207652 @default.
• W2513500912 cites W2083120140 @default.
• W2513500912 cites W2085011183 @default.
• W2513500912 cites W2085255789 @default.
• W2513500912 cites W2093136411 @default.
• W2513500912 cites W2103735388 @default.
• W2513500912 cites W2120867943 @default.
• W2513500912 cites W2121741072 @default.
• W2513500912 cites W2123326168 @default.
• W2513500912 cites W2124863719 @default.
• W2513500912 cites W2130767844 @default.
• W2513500912 cites W2138008191 @default.
• W2513500912 cites W2138226825 @default.
• W2513500912 cites W2143904165 @default.
• W2513500912 cites W2144590229 @default.
• W2513500912 cites W2154675049 @default.
• W2513500912 cites W2158822657 @default.
• W2513500912 cites W2160635124 @default.
• W2513500912 cites W2167607459 @default.
• W2513500912 cites W4253515290 @default.
• W2513500912 doi "https://doi.org/10.1016/j.ijcard.2016.08.158" @default.
• W2513500912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27552564" @default.
• W2513500912 hasPublicationYear "2016" @default.
• W2513500912 type Work @default.
• W2513500912 sameAs 2513500912 @default.
• W2513500912 citedByCount "39" @default.
• W2513500912 countsByYear W25135009122016 @default.
• W2513500912 countsByYear W25135009122017 @default.
• W2513500912 countsByYear W25135009122018 @default.
• W2513500912 countsByYear W25135009122019 @default.
• W2513500912 countsByYear W25135009122020 @default.
• W2513500912 countsByYear W25135009122021 @default.
• W2513500912 countsByYear W25135009122022 @default.
• W2513500912 countsByYear W25135009122023 @default.
• W2513500912 crossrefType "journal-article" @default.
• W2513500912 hasAuthorship W2513500912A5003150097 @default.
• W2513500912 hasAuthorship W2513500912A5004471228 @default.
• W2513500912 hasAuthorship W2513500912A5009540446 @default.
• W2513500912 hasAuthorship W2513500912A5011798535 @default.
• W2513500912 hasAuthorship W2513500912A5021022068 @default.
• W2513500912 hasAuthorship W2513500912A5026554167 @default.
• W2513500912 hasAuthorship W2513500912A5041985799 @default.
• W2513500912 hasAuthorship W2513500912A5042394356 @default.
• W2513500912 hasAuthorship W2513500912A5050261399 @default.
• W2513500912 hasAuthorship W2513500912A5077187848 @default.
• W2513500912 hasAuthorship W2513500912A5081352430 @default.
• W2513500912 hasConcept C126322002 @default.
• W2513500912 hasConcept C134018914 @default.
• W2513500912 hasConcept C2776919658 @default.
• W2513500912 hasConcept C2777180221 @default.
• W2513500912 hasConcept C2777391703 @default.
• W2513500912 hasConcept C2778163477 @default.
• W2513500912 hasConcept C2778270857 @default.
• W2513500912 hasConcept C2778913445 @default.
• W2513500912 hasConcept C2780578515 @default.
• W2513500912 hasConcept C2780988686 @default.
• W2513500912 hasConcept C2910068830 @default.
• W2513500912 hasConcept C3018667095 @default.
• W2513500912 hasConcept C555293320 @default.
• W2513500912 hasConcept C71924100 @default.
• W2513500912 hasConceptScore W2513500912C126322002 @default.
• W2513500912 hasConceptScore W2513500912C134018914 @default.
• W2513500912 hasConceptScore W2513500912C2776919658 @default.
• W2513500912 hasConceptScore W2513500912C2777180221 @default.

• next